Through 2020, Rib-X’s Radezolid Will Be the Only Agent to Launch for Community-Acquired Bacterial Pneumonia – Newsblaze.com

These include penicillin-, macrolide- and quinolone-resistant Streptococcus pneumoniae as well as community-acquired methicillin-resistant Staphylococcus aureus, which are a growing concern in CABP. “Development activity for CABP is the highest …